HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$0.75
Day range
$0.73 - $0.76
Year range
$0.70 - $25.26
Market cap
2.85M USD
Avg Volume
920.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.80M | -35.32% |
Net income | -2.24M | 14.72% |
Net profit margin | — | — |
Earnings per share | -0.84 | 93.52% |
EBITDA | -1.79M | 35.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.54M | -53.26% |
Total assets | 6.74M | -52.60% |
Total liabilities | 4.07M | -24.69% |
Total equity | 2.67M | — |
Shares outstanding | 4.29M | — |
Price to book | 1.21 | — |
Return on assets | -47.26% | — |
Return on capital | -235.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.24M | 14.72% |
Cash from operations | -9.26M | -439.24% |
Cash from investing | -17.69K | — |
Cash from financing | 3.74M | — |
Net change in cash | -5.53M | -222.25% |
Free cash flow | -8.16M | -889.22% |
About
Founded
2019
Website
Employees
9
